+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Retrophin Inc - logo

Retrophin is a biopharmaceutical company that is based in San Diego, California. The company’s leading pipeline assets are fosmetpantotenate (RE-024), is a life-threatening neurological disorder that typically begins in early childhood, and sparsentan for focal segmental glomerulosclerosis (FSGS), a serious kidney disorder that often leads to end-stage renal disease. Its marketed products include Chenodal, Cholbam and Thiola. Retrophin was founded in 2011.

Cardiovascular Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 300 Pages
  • Global
From
Glomerulonephritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Glomerulonephritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 322 Pages
  • Global
From
From
From
Cystinuria Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cystinuria Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Loading Indicator